Health Condition 1: E119- Type 2 diabetes mellitus without complications
Conditions
Interventions
Intervention1: Medisafe Mobile Application: A smartphone-based platform designed to support patients in managing their medication schedules through features like timely reminders, dose tracking, adher
Sponsors
Nil
Eligibility
Inclusion criteria
Inclusion criteria: Adults aged 18 70 years with type 2 diabetes mellitus On stable oral hypoglycemic agents insulin for at least 3 months Owns a smartphone (for Medisafe arm) Provides informed consent.
Exclusion criteria
Exclusion criteria: Cognitive impairment or psychiatric illness interfering with adherence. Severe diabetic complications (e.g., end-stage renal disease, advanced retinopathy). Participation in another adherence-related trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Medication adherence measured using: MARS Medication Adherence Scale (MARS 5) at baseline and 24 week Pill count method at each follow-up visit. Timepoint: Baseline and 24 Weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in HbA1c at baseline and at the end of 12 weeks and 24 weeks Fasting and postprandial blood glucose values. Renal parameters like blood urea, serum creatinine and spot urine albumin creatinine ratio were reassessed after 12 and 24 weeks and compared with the baseline values Patient satisfaction and ease-of-use (Likert scale questionnaire). Timepoint: 12 weeks and 24 Weeks | — |
Countries
India
Contacts
Public ContactShatavisa Mukherjee
School of Tropical Medicine, Kolkata
Outcome results
None listed